|
CN112110926A
|
|
Method for preparing tebipenem pivoxil
|
|
CN111821307A
|
|
17- (3-pyridyl) androstane-5, 16-diene-3 beta-alcohol acetate solid preparation and preparation method thereof
|
|
CN111624276A
|
|
Method for simultaneously detecting genotoxic impurities 5-isoquinoline methyl sulfonate and 5-isoquinoline ethyl sulfonate in fasudil hydrochloride
|
|
CN111307985A
|
|
Method for detecting genotoxic impurities in antihypertensive drug intermediate
|
|
CN111253315A
|
|
Imidapril hydrochloride organic impurity and preparation method thereof
|
|
CN111239286A
|
|
Method for detecting genotoxic impurities in tenofovir
|
|
CN111239285A
|
|
Method for detecting content of genotoxic impurities in Tenofovir alafenamide
|
|
CN111249248A
|
|
Blood lipid reducing medicine and preparation method thereof
|
|
CN110483312A
|
|
A kind of preparation method of high-purity hydrochloric acid Ivabradine and its intermediate
|
|
CN111096955A
|
|
Preparation method of azilsartan tablets
|
|
CN108743554A
|
|
A kind of toluenesulfonic acid Yi Dushaban tablets and preparation method thereof
|
|
CN108553441A
|
|
A kind of Apixaban tablet and preparation method thereof
|
|
CN108484641A
|
|
The preparation method of Yi Dushaban tosilate monohydrates
|
|
CN103664837A
|
|
Preparation method of high-purity cabazitaxel intermediate
|
|
CN102321057A
|
|
The substituted methylsulfonyl amido-benzofuran derivative of N-, Preparation Method And The Use
|
|
CN102010359A
|
|
Method for preparing silodosin in beta crystal form
|
